================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K SB [X] Current Report Persuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Original Report: June 12, 1998 Commission File Number 0-9860 ------------- ------ BIOSEARCH MEDICAL PRODUCTS, INC. -------------------------------- (Exact name of registrant as specified in its charter) New Jersey 22-2090421 ------------------------------- ---------------- (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) 35 Industrial Parkway, Somerville, New Jersey 08876-1276 - --------------------------------------------- ----------------- (Address of principal executive offices) (Zip Code + 4) Registrant's telephone number, including area code: (908) 722-5000 --------------- ================================================================================ Item 1: N/A Item 2: ACQUISITION AND DISPOSITION OF ASSETS Biosearch Medical Products Inc. announced today, June 12, 1998, it has sold its property at 35 Industrial Parkway, Branchburg to Hydromer Inc. for the sum of $850,000 and a prepaid lease back of approximately two thirds of the building for the three years with a value of approximately $346,500 bringing the value of the total deal to $1,196,500. With this transaction Biosearch Medical Products will pay off Summit Bank and all judgements against it have been dismissed. Hydromer Inc. is an affiliated party. Manfred F. Dyck is Chairman of the Board of Directors and Chief Executive Officer of Biosearch Medical Products Inc. and Director, President and Chief Executive Officer of Hydromer Inc. He holds a substantial amount of stock in both companies as noted in the Company's proxy statement and Hydromer's proxy statement. 1 Item 3: N/A Item 4: N/A Item 5: N/A Item 6: N/A Item 7: N/A BIOSEARCH MEDICAL PRODUCTS, INC. By: /s/ Robert C. Keller ------------------------- Robert C. Keller Vice President Finance Chief Financial Officer Attested By: /s/ Robert J. Moravsik ------------------------- Robert J. Moravsik Vice President, General Counsel and Secretary 2